Femasys Inc. Files 8-K Report
Ticker: FEMY · Form: 8-K · Filed: Nov 10, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Nov 10, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, sec
TL;DR
Femasys Inc. filed an 8-K on Nov 10, 2025. Details pending.
AI Summary
On November 10, 2025, Femasys Inc. filed an 8-K report. The filing indicates that the report is a current report and includes information on "Other Events" and "Financial Statements and Exhibits." No specific financial figures or event details were provided in the excerpt.
Why It Matters
This filing signals that Femasys Inc. is providing updated information to the SEC, which could include material events or financial updates relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural report without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- Femasys Inc. (company) — Registrant
- November 10, 2025 (date) — Date of earliest event reported
- 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024 (address) — Principal executive offices
- 770-500-3910 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Femasys Inc.?
The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating the reporting of "Other Events" and "Financial Statements and Exhibits."
When was the earliest event reported in this filing?
The earliest event reported was on November 10, 2025.
What is Femasys Inc.'s principal executive office address?
The principal executive offices are located at 3950 Johns Creek Court, Suite 100, Suwanee, Georgia 30024.
What is the SEC file number for Femasys Inc.?
The SEC file number for Femasys Inc. is 001-40492.
What is the SIC code for Femasys Inc.?
The Standard Industrial Classification (SIC) code for Femasys Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 10.2 · Accepted 2025-11-10 09:22:58
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY The Nasdaq Stock Mar
Filing Documents
- ef20058658_form8k.htm (8-K) — 27KB
- ef20058658_ex99-1.htm (EX-99.1) — 15KB
- logo1.jpg (GRAPHIC) — 5KB
- 0001140361-25-041293.txt ( ) — 185KB
- femy-20251110.xsd (EX-101.SCH) — 4KB
- femy-20251110_lab.xml (EX-101.LAB) — 22KB
- femy-20251110_pre.xml (EX-101.PRE) — 16KB
- ef20058658_form8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events On November 10, 2025, Femasys Inc. (the "Company") issued a press release announcing that Femasys Advances Global Growth with Second Partner Order for FemBloc in Europe. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Femasys Inc. dated November 10, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: November 10, 2025